Asia Pacific Cancer Tissue Diagnostics Market to 2027 - Regional Analysis and Forecasts By Test Type (Immunohistochemical Tests and In Situ Hybridization Tests) and Country.
- THE3479211
- 150 Pages
- January 2020
- Diagnostic and Biotech
The growth of the cancer tissue diagnostics market during the forecast period is primarily attributed to factors like the rising number of cancer patients in the Asia Pacific and technological advancements and product launches in Asian Countries. On the other hand, the emerging countries in the Asia Pacific region are expected to have opportunities for growth of the Asia Pacific cancer tissue diagnostics market in the coming years.
The Asia Pacific region is a diverse and densely populated region with around 4.5 billion population (as of 2016) and accounts for 60% of the world population. According to the American Cancer Society, Inc., in 2018, approximately 8.2 million new cancer cases were diagnosed, and about 5.2 million cancer deaths were estimated in the Southern, Eastern, and South-Eastern Asia, which is around half of the cancer burden worldwide. The report also mentioned that China accounts for 52% of new cancer cases, which is around 4.3 million new cases, and 55% of cancer deaths that are around 2.9 million cancer deaths in the region. According to the cancer factsheet by the National Institute of Cancer Prevention and Research (NICPR), the Indian Council of Medical Research (ICMR), in 2018, in India, total deaths due to cancer were 7,84,821, of which 4,13,519 were male deaths, and 3,71,302 were female deaths. The report also mentioned that in India, one woman dies every 8 minutes due to cervical cancer.
The Asia Pacific region follows most of the global trends for common cancer types and has some key differences. For instance, in Asia, the most common type of cancer in men is lung cancer, while in the West, it is prostate cancer. Also, in Asian females, breast cancer is the most common type of cancer. However, cervical and liver cancers occur more frequently in other regions.
Thus the growing prevalence of cancer is likely to demand new diagnostics techniques, which will drive the growth of the cancer tissue diagnostics market during the forecast period.
Asia Pacific cancer tissue diagnostics market is segmented into test type. Based on the test type, the cancer tissue diagnostics market is categorized as immunohistochemical tests and in situ hybridization tests. The immunohistochemical tests market held the largest share in 2018 and is also expected to witness rapid growth during the forecast period.
Some of the major primary and secondary sources for cancer tissue diagnostics market included in the report are World Health Organization (WHO), United Nations Population Fund, Food and Drug Administration (FDA), National Institute of Cancer Prevention and Research (NICPR), the Indian Council of Medical Research (ICMR), among others.
1. Introduction
1.1 Scope of The Study
1.2 The Insight Partners Research Report Guidance
2. Asia Pacific Cancer Tissue Diagnostics Market – Key Takeaways
3. Asia Pacific Cancer Tissue Diagnostics Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Asia Pacific Cancer Tissue Diagnostics Market – By Test Type
3.2.2 Asia Pacific Cancer Tissue Diagnostics Market – By Country
3.3 PEST Analysis
3.4 Expert Opinions
4. Asia Pacific Cancer Tissue Diagnostics Market-Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Number of Cancer Patients In Asia Pacific
4.1.2 Technological Advancements and Product Launches in Asian Countries
4.2 Key Market Restraints
4.2.1 Lack Of Resources and Awareness For Cancer Screening And Treatment in Poor/ Less Developed Countries
4.3 Key Market Opportunities
4.3.1 Emerging Countries in Asia Pacific Region
4.4 Future Trends
4.4.1 Growing Trend of Personalized Medicine
4.5 Impact Analysis Of Drivers And Restraints
5. Cancer Tissue Diagnostics Market – Asia Pacific Analysis
5.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis
5.2 Performance of Key Players
6. Asia Pacific Cancer Tissue Diagnostics Market Analysis– by Test Type
6.1 Overview
6.2 Asia Pacific Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)
6.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027, By Type Of Fitting (Us$ Mn)
6.4 Immunohistochemical Tests Market
6.4.1 Overview
6.4.2 Asia Pacific Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.3 Breast Cancer Market
6.4.3.1 Overview
6.4.3.2 Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.4 Colorectal Cancer Market
6.4.4.1 Overview
6.4.4.2 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.5 Prostate Cancer Market
6.4.5.1 Overview
6.4.5.2 Asia Pacific Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.6 Stomach Cancer Market
6.4.6.1 Overview
6.4.6.2 Asia Pacific Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.7 Others Market
6.4.7.1 Overview
6.4.7.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 In Situ Hybridization Tests Market
6.5.1 Overview
6.5.2 Asia Pacific In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.3 Breast Cancer Market
6.5.3.1 Overview
6.5.3.2 Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.4 Lung Cancer Market
6.5.4.1 Overview
6.5.4.2 Asia Pacific Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.5 Bladder Cancer Market
6.5.5.1 Overview
6.5.5.2 Asia Pacific Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.6 Others Market
6.5.6.1 Overview
6.5.6.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
7. Asia Pacific Cancer Tissue Diagnostics Market
7.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027
7.1.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.2 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.2.1 Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.2.2 Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
7.1.4 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.4.1 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.4.2 Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.4.2.1 Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.4.2.2 Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.5 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.5.1 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.5.2 China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.5.2.1 China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.5.2.2 China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.6 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.6.1 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.6.2 India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.6.2.1 India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.6.2.2 India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.7 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.7.1 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.7.2 South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.7.2.1 South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.7.2.2 South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.8 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.8.1 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.8.2 Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.8.2.1 Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.8.2.2 Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8. Cancer Tissue Diagnostics Market– Industry Landscape
8.1 Overview
8.2 Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019
8.3 Organic Growth Strategies
8.3.1 Overview
8.4 Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
8.4.1 Product Launches
8.4.1.1 Recent Product Launches By Players In The Cancer Tissue Diagnostics Market
8.4.2 Product Approvals
8.4.2.1 Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market
8.4.3 Expansion & Other Activities
8.4.3.1 Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
8.4.4 Product Enhancements
8.4.4.1 Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
8.5 Inorganic Growth Strategies
8.5.1 Overview
8.6 Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
8.6.1 Agreements
8.6.1.1 Recent Agreements By Players In The Cancer Tissue Diagnostics Market
8.6.2 Partnerships & Collaborations
8.6.2.1 Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
8.6.3 Acquisitions
8.6.3.1 Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
9. Cancer Tissue Diagnostics Market–Key Company Profiles
9.1 Bio-Rad Laboratories, Inc.
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Financial Information
9.1.4 Product Portfolio
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Financial Information
9.2.4 Product Portfolio
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Financial Overview
9.3.4 Product Portfolio
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 Abbott
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Financial Overview
9.4.4 Product Portfolio
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 Enzo Biochem Inc.
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Financial Overview
9.5.4 Product Portfolio
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 Agilent Technologies, Inc.
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Financial Overview
9.6.4 Product Portfolio
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 Cancer Genetics Inc.
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Financial Overview
9.7.4 Product Portfolio
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 Merck Kgaa (Sigma-Aldrich)
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Financial Overview
9.8.4 Product Portfolio
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 Abcam Plc.
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Financial Overview
9.9.4 Product Portfolio
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 Danaher
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Financial Information
9.10.4 Product Portfolio
9.10.5 SWOT Analysis
9.10.6 Key Developments
10. Appendix
10.1 About The Insight Partners
10.2 Glossary Of Terms
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Primary Research
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
